HITS

DRUG2 trials

Sponsors

Far Eastern Memorial Hospital, Fundació Sant Joan de Déu

Conditions

Cutaneous T-cell LymphomaRefractory NeuroblastomaSoft Tissue Cancer

Phase 2

A Study Of Naxitamab , Granulocyte Macrophage Colony Stimulating Factor For Patients With Relapsed /Refractory , Soft Tissue or Anti GD2 Immunotherapy Refractory Neuroblastoma

CompletedNCT06438614

Fundació Sant Joan de DéuRefractory Neuroblastoma, Soft Tissue Cancer

Start: 2020-08-20End: 2023-10-24Updated: 2024-08-29

Unknown Phase

Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma

Far Eastern Memorial HospitalCutaneous T-cell Lymphoma

Start: 2014-01-31End: 2017-12-31Target: 10Updated: 2014-08-04